Friday, 24 August 2012

Loeys-Dietz syndrome

Recently described, Loeys-Dietz syndrome is phenotypically distinct from Marfan syndrome.
Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder showing the involvement of cutaneous, cardiovascular, craniofacial, and skeletal systems. In particular, LDS patients show arterial tortuosity with widespread vascular aneurysm and dissection, and have a high risk of
 aortic dissection or rupture at an early age and at aortic diameters that ordinarily are not predictive of these events. Recently, LDS has been subdivided in LDS type I (LDSI) and type II (LDSII) on the basis of the presence or the absence of cranio-facial involvement, respectively. Furthermore, LDSII patients display at least two of the major signs of vascular Ehlers-Danlos syndrome. LDS is caused by mutations in the transforming growth factor (TGF) beta-receptor I (TGFBR1) and II (TGFBR2) genes. The aim of this study was the clinical and molecular characterization of two LDS patients.

Methods
The exons and intronic flanking regions of TGFBR1 and TGFBR2 genes were amplified and sequence analysis was performed.

Results
Patient 1 was a boy showing dysmorphic signs, blue sclerae, high-arched palate, bifid uvula; skeletal system involvement, joint hypermobility, velvety and translucent skin, aortic root dilatation, tortuosity and elongation of the carotid arteries. These signs are consistent with an LDSI phenotype. The sequencing analysis disclosed the novel TGFBR1 p.Asp351Gly de novo mutation falling in the kinase domain of the receptor. Patient 2 was an adult woman showing ascending aorta aneurysm, with vascular complications following surgery intervention. Velvety and translucent skin, venous varicosities and wrist dislocation were present. These signs are consistent with an LDSII phenotype. In this patient and in her daughter, TGFBR2 genotyping disclosed in the kinase domain of the protein the novel p.Ile510Ser missense mutation.

Conclusion
We report two novel mutations in the TGFBR1 and TGFBR2 genes in two patients affected with LDS and showing marked phenotypic variability. Due to the difficulties in the clinical approach to a TGFBR-related disease, among patients with vascular involvement, with or without aortic root dilatation and LDS cardinal features, genotyping is mandatory to clarify the diagnosis, and to assess the management, prognosis, and counselling issues.

IN THIS PICTURE:
Clinical and radiographic features of the two LDS Patients. A) Phenotype of Patient 1, showing facial dysmorphisms: dolichocephaly, hypoplastic alae nasi, and micro/retrognathia; marfanoid habitus, muscular hypotrophy, mild thoracic scoliosis, and pes planus. B) Patient 2: Ascending aorta dilatation (i) and MRI axial T1 spin-echo images of the ascending aorta at the level of re-implanted coronary arteries, before (ii) and after (iii) gadolinium: a periaortic collection is visible (arrows), with contrast medium outside the aortic graft, due to detachment of re-implanted left coronary artery. C) Translucent skin with subcutaneous visible veins and flat feet in Patient 2.





MEASLES

Before immunisation campaigns, measles occurred in
almost 100% of children world-wide. The WHO has set
the objective of eradicating measles globally by 2010,
using the live attenuated vaccine. However, vaccination
of only 70–80% of the population, as is currently
the case in the UK, for example, is insufficient to prevent
outbreaks in older children and adults, who are more
susceptible to complications. Natural illness produces
lifelong immunity.

Clinical features:

Infection is by respiratory droplets with an incubation
period of 6–19 days. A prodromal illness, 1–3 days before
the rash, occurs with upper respiratory symptoms, conjunctivitis
and the presence of Koplik’s spots on the interinternal
buccal mucosa. These small white spots
surrounded by erythema are pathognomonic of measles.
As natural antibody develops, the maculopapular rash
appears, spreading from the face to the extremities.
Generalised lymphadenopathy and diarrhoea
are common, with otitis media and bacterial pneumonia
recognised complications. Clinical encephalitis occurs in
approximately 0.1% of children. A rare late complication is
subacute sclerosing panencephalitis (SSPE), which occurs
up to 7 years after infection.

Diagnosis is clinical (although this is unreliable in areas where measles is no longer common) and by detection of antibody (serum IgM, seroconversion or salivary IgM).

Disease is more severe and prolonged in adults and complications
include pneumonitis, hepatitis and encephalitis. Measles is a serious disease in the malnourished, vitamindeficient or immunocompromised, in whom the typical rash may be missing and persistent infection with a giant cell pneumonitis or encephalitis may occur. In tuberculosis infection, measles suppresses cell-mediated immunity and
may exacerbate disease; for this reason, measles vaccination
should be deferred until after commencing antituberculous
treatment. Measles does not cause congenital malformation
but may be more severe in pregnant women.
Mortality clusters at the extremes of age, averaging
1:1000 in developed countries and up to 1:4 in developing
countries. Death usually results from bacterial superinfection
such as pneumonia, diarrhoeal disease or noma/
cancrum oris.

Management and prevention:

Normal immunoglobulin attenuates the disease in the
immunocompromised (regardless of vaccination status)
and in non-immune pregnant women, but must be given
within 6 days of exposure. Vaccination can be used in
outbreaks and vitamin A may improve the outcome in
uncomplicated disease. Antibiotic therapy is reserved
for bacterial complications.
All children aged 12–15 months (when maternal antibody
will no longer be present) should receive measles
vaccination (as combined measles, mumps and rubella
(MMR), a live attenuated vaccine), and a further MMR
dose at the age of 4 years.




source